<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92930</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Fibroziruyushchiy al'veolit kak debyut polimiozita s tyazhelym antisintetaznym sindromom</article-title><trans-title-group xml:lang="ru"><trans-title>Фиброзирующий альвеолит как дебют полимиозита с тяжелым антисинтетазным синдромом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bondarenko</surname><given-names>I. B</given-names></name><name xml:lang="ru"><surname>Бондаренко</surname><given-names>И. Б</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Antelava</surname><given-names>O. A</given-names></name><name xml:lang="ru"><surname>Антелава</surname><given-names>О. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff4"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nasonov</surname><given-names>E. L</given-names></name><name xml:lang="ru"><surname>Насонов</surname><given-names>Е. Л</given-names></name></name-alternatives><xref ref-type="aff" rid="aff4"/><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ММА им. И.М.Сеченова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="ru">Институт ревматологии РАМН, Москва</institution></aff><aff><institution xml:lang="en"></institution></aff></aff-alternatives><aff id="aff3"><institution>Институт ревматологии РАМН, Москва</institution></aff><aff id="aff4"><institution>ММА им. И.М.Сеченова</institution></aff><pub-date date-type="pub" iso-8601-date="2009-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2009</year></pub-date><volume>11</volume><issue>3</issue><issue-title xml:lang="en">VOL 11, NO3 (2009)</issue-title><issue-title xml:lang="ru">ТОМ 11, №3 (2009)</issue-title><fpage>81</fpage><lpage>83</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/92930">https://consilium.orscience.ru/2075-1753/article/view/92930</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>полимиозит</kwd><kwd>дерматомиозит</kwd><kwd>мышечные расстройства</kwd><kwd>фиброзирующий альвеолит</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Антелава О.А., Соловьев С.К,. Хитров А.Н, Насонов Е.Л. Новые аспекты фармакотерапии идиопатических воспалительных миопатий (Обзор литературы). Рус. мед. журн. 2006; 14 (8): 260, 627–9.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. Поражение легких при полимиозите и дерматомиозите. Интерстициальные заболевания легких. Руководство для врачей. Под ред. М.М. Ильковича, А.Н. Кокосова. Спб.: Нордмедиздат, 2005: 274–87.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. и др. Поражение легких при полимиозите и дерматомиозите. Клин. мед. 1998; 2: 20–4.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Насонов Е.Л., Штутман В.З., Саложин К.В. и др. Клинико - иммунологическая гетерогенность идиопатических воспалительных миопатий. Клин. мед. 1995; 2: 4–8.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Идиопатические воспалительные миопатии. Клинические рекомендации. Ревматология. М., 2005: 192–201.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Овчаренко С.И., Петухова Н.В., Слукина О.Г. Поражение легких по типу интерстициальной болезни у больной с дерматомиозитом. Новые Санкт - Петербургские врачебные ведомости. 2001; 2: 49–51.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Adansson J.Y. Radiation enhaces silica translocation to the pulmonary interstitium and increases fibrosis in mice. Environ Health Perspekt. 1992; 97: 233–8.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Asanuma Y, Yamada H, Matsuda T et al. Successful treatment of interstitial pneumonia with lipo - PGE1 and pentoxilylline in a patient with dermatomyositis. Ryumachi 1997; 37 (5): 719–26.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bach G.L., Stock K-P. Polymyositis/Dermatomyositis: Klinik, Aetiopathogenese und moegliche ausloesende Faktoren. Artritis + Rheuma 1992; 12 (1): 20–4.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Betteridge Z, Gunawardena H, North J et al. Ant - synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti - Zo) assotiated with polymyositis and interstitial pneumonia. Rheumatol 2007; 46: 1005–8.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Blechynden L.M., Lawson M.A., Tabarias H et al. Myositis induced by naked DNA immunization with the gene for hystidyl - tRNA. Hum Gene Ther 1997; 8 (12): 1469–80.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Duncan P.E., Criffin J.P., Garcia A. Fibrosing alveolitis in polymyositis: a review of histologically cases. Am J Med 1974; 57: 621–6.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Fathi М, Vikgren J, Boijsen M et al. Interstitial lung disease in Polymyositis and Dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arth Rheu (Arth Care Res) 2008; 59 (5): 677–85.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hashish L, Trieu E.P., Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl - tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (absract). Arth Rheum 2005; 52 (Suppl. 9): 312.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hirakata H, Suwa A, Takeda Y et al. Electronic cell conting to measure total cell numbers in bronchoalveolarlavage fluid. Eur Respir J 1994; 7: 1527–31.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Yoshifuji H, Fujii T, Kobayashi S et al. Anti - aminoacyl - tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 233–41.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Ishikawa S, Takei Y, Maruyama T, Koyama S, Hanyu N. A case of polymyositis presenting pregnancy with acute respiratory failure. Rinsho-Shinkeigaku 2000; 40 (2): 140–4.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mаrir I.E., Hachulla P, Erin S. Interstitial Lung Disease in Polymyositis and Dermatomyositis Arthritis &amp; Rheumatism (Arth Res) 2002; 47 (6): 614–22.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Mills E.S., Matheus W.H. Interstitial pneumonitis in dermatomyositis. JAMA 1956; 160: 1467–70.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Nishikai M, Ohya K, Kosaka M et al. Anti - Jo - 1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 1998; 37 (4): 357–61.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>O\'Leary P.A., Waisman M. Dermatomyositis: A stady of forty cases. Arch.Dermatol.Syph 1940; 41: 1001–19.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Philips T, Leigh I, Wright J. Dermatomyositis and pulmonary fibrosis associated with anti - Jo - 1 antibody. J of the Am Acad Dermatol 1988; 5: 381–2.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Rowen A.J., Reiched J. Dermatomyositiswith lung involvement treated with azathioprine. Resperation 1983; 44: 143–6.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Salaffi F, Carotti M, Baldelli S et al. Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings. Radiol Med Torino 1999; 97 (1–2): 33–41.</mixed-citation></ref></ref-list></back></article>
